Temporal trend of mortality in patients with cirrhosis with primary biliary cholangitis and primary sclerosing cholangitis during the COVID-19 pandemic

Xinyuan He^#¹, Ning Gao^#¹, Fan Lv², Fengping Wu¹, Yi Liu¹, Lamei Li¹, Walid S Ayoub^{3

4}, Yee Hui Yeo^#⁵, Fanpu Ji^#^{6

7

8

9}

Affiliations

¹ Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
² School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
³ Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
⁴ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
⁵ Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA yeehui.yeo@cshs.org jifanpu1979@163.com.
⁶ Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China yeehui.yeo@cshs.org jifanpu1979@163.com.
⁷ National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
⁸ Shaanxi Provincial Clinical Medical Research Center of Infectious Diseases, Xi'an, Shaanxi, China.
⁹ Key Laboratory of Surgical Critical Care and Life Support (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.

^# Contributed equally.

Comment

Xinyuan He et al. Gut. 2024.

. 2024 Jun 6;73(7):1217-1219.

doi: 10.1136/gutjnl-2023-330271.

Xinyuan He^#¹, Ning Gao^#¹, Fan Lv², Fengping Wu¹, Yi Liu¹, Lamei Li¹, Walid S Ayoub^{3

4}, Yee Hui Yeo^#⁵, Fanpu Ji^#^{6

7

8

9}

¹ Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
² School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
³ Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
⁴ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
⁵ Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA yeehui.yeo@cshs.org jifanpu1979@163.com.
⁶ Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China yeehui.yeo@cshs.org jifanpu1979@163.com.
⁷ National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
⁸ Shaanxi Provincial Clinical Medical Research Center of Infectious Diseases, Xi'an, Shaanxi, China.
⁹ Key Laboratory of Surgical Critical Care and Life Support (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.

^# Contributed equally.

No abstract available

Keywords: CIRRHOSIS; COVID-19; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS.

Conflict of interest statement

Competing interests: FJ: Speaker: Gilead Sciences, MSD and Ascletis. Consulting/advisory board: Gilead, MSD.

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J, Lucena A, Hernández-Guerra M, Moreno-Moraleda I, Arenas J, Conde I, Muñoz L, Canillas L, Fernandez E, Quiñones R, Simon MA, Gómez-Dominguez E, Gutierrez ML, Fernandez-Rodriguez C, Domper-Arnal MJ, Jorquera F, Garcia-Buey ML, Garcia-Retortillo M, Morillas R, Berenguer M, Casado M, Morales-Arraez D, Sousa JM, Molina E. Ampuero J, et al. Gut. 2021 Dec 7:gutjnl-2021-325700. doi: 10.1136/gutjnl-2021-325700. Online ahead of print. Gut. 2021. PMID: 34876479 No abstract available.